Open Payments Database Notice

Raymond Douglas, MD, PhD

THYROID EYE DISEASE TREATMENT SPECIALIST | OCULOPLASTIC SURGERY & AESTHETICS

Dr Raymond Douglas | Best Oculoplastic Surgeon Beverly Hills

We're Expanding to Serve You Better! Now in Las Vegas!

Visit Our New Location at Summerlin Medical Center 653 N Town Center Dr. Suite 512

Dr Raymond Douglas | Best Oculoplastic Surgeon Beverly Hills

About Dr. Douglas

Raymond Douglas, MD, PhD, is a world-renowned, board-certified aesthetic and reconstructive oculoplastic surgeon in Beverly Hills, California. He specializes in aesthetic and reconstructive oculoplastic surgery as well as thyroid eye disease (TED) treatment and transformations. He is one of the lead scientists in the development of the only FDA approved treatment for TED (Tepezza) and has pioneered many techniques in aesthetic TED transformation.

Dr. Douglas graduated with academic distinction from the University of Pennsylvania, where he completed his medical training and his doctorate in immunology. He then finished an orbitofacial plastic and reconstructive surgery

Raymond Douglas, MD PhD offers a customized approach to Thyroid Eye Disease Surgery

As a Thyroid Eye Disease (TED) specialist, Dr. Raymond Douglas believes that every patient deserves a treatment that is customized to their exact needs, as no two patients are exactly the same. An aesthetic customized approach to TED is important because not only does it correct the functional issues associated with the disease, but it also allows the patient to look and feel their best.

Many patients often feel guilty thinking about undergoing the surgery, but no one would ever think twice about fixing a facial fracture after a car accident. In this same vein, we want patients with Graves’ eye disease or TED to know they should not feel guilty about wanting to restore their appearance to their pre-disease look. Dr. Douglas offers a customized approach for each patient, both surgical and non-surgical. Click here to learn more about TEPEZZA!

Latest News

Endocrine Society | Thyroid Eye Disease

Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions

Mary Ann Liebert | Thyroid Eyes Treatment

A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease

New England Journal of Medicine | Thyroid Eyes Treatment

Teprotumumab for the Treatment of Active Thyroid Eye Disease